http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2533286-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f81ee923d3c8335ce0702b85a3f90f5 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc58a159679ba941ef73aeebb2a89d61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d156c6f970a044aea2a7ff34ffeb5c59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e43d1916df255c8550514676722f3970 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ff90b641ca33ccda26ca0d913874a7a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9ed14496d545148160e3909ebd91d2 |
publicationDate | 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2533286-C1 |
titleOfInvention | Method for prediction of clinical course and treatment efficacy of type 2 diabetes mellitus |
abstract | FIELD: medicine. n SUBSTANCE: after DNA is recovered from peripheral venous blood, a polymorphic version +250A/G of a lymphotoxin α (Ltα) gene is analysed. If the genotype +250GG Ltα is found, the favourable course of type 2 diabetes mellitus is predicted, and therapy with oral antihyperglycemic drugs is expected to have a positive effect. n EFFECT: invention provides deriving new assessment criteria of the clinical course and treatment efficacy in Russian individuals suffering from type 2 diabetes mellitus. n 4 dwg, 1 tbl, 1 ex |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2626670-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2602663-C1 |
priorityDate | 2013-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 154.